2023-506882-70-00暂停3 期
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer
H e x a l AG23 个研究点 分布在 3 个国家目标入组 89 人开始时间: 2024年4月19日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 暂停
- 发起方
- 入组人数
- 89
- 试验地点
- 23
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Biosimilar Clinical Trials Information Point
Scientific
H e x a l AG
研究点 (23)
Loading locations...
相似试验
招募中
1 期
Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers.2024-516008-41-00Virometix AG60
进行中（未招募）
3 期
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49NCT07284654Vaxcyte, Inc.4,049
进行中（未招募）
2 期
Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveNCT07285278Suzhou Abogen Biosciences Co., Ltd.300
招募中
2 期
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in InfantsNCT07286370GlaxoSmithKline537
进行中（未招募）
1 期
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.NCT07280858SK Bioscience Co., Ltd.368